소아청소년과
김은실
진료분야 크론병, 궤양성 대장염, 복통, 구토, 변비, 설사, 혈변, 황달, 간염, 소아비만, 저체중, , 섭식장애, 영양치료, 소아내시경
진료예약모바일로 확인하실 경우 표를 좌우로 움직여 내용을 확인 하실 수 있습니다.
| 0000 00 |
|---|
| 오전 |
| 오후 |
진료과 사정에 따라 진료 일정이 변경될 수 있습니다. 자세한 일정은 진료과로 문의 바랍니다.
- 외래진료
- 국내 학회
- 국외 학회
- 강의
- 휴가
- 기타
| 0000 00 |
|---|
| 오전 |
| 오후 |
진료과 사정에 따라 진료 일정이 변경될 수 있습니다. 자세한 일정은 진료과로 문의 바랍니다.
- 외래진료
- 국내 학회
- 국외 학회
- 강의
- 휴가
- 기타
- 논문 더보기
-
- Kim ES, Kwon Y, Choe YH, Kim MJ. Free antibodies-to-infliximab are biomarker for predicting the effect of dose intensification in pediatric Crohn's disease patients with secondary loss of response. Therap Adv Gastroenterol. 2023 May 6;16:17562848231170948.
- Choi SY, Kim ES, Jeon TY, Lee YM, Lee SM, Choe BH, Choe YH, Kang B. Transmural Transmural healing evaluated by magnetic resonance enterography in paediatric patients with Crohn's disease receiving maintenance treatment with biologics. Aliment Pharmacol Ther. 2022 Jul 23. doi: 10.1111/apt.17161. Epub ahead of print.
- Kim ES, Choi S, Choi SY, Park JH, Choe BH, Lee SY, Kim MJ, Choe YH, Kang B. NUDT15 intermediate metabolisers are associated with lower loss of response in paediatric Crohn's disease patients treated by combination treatment with infliximab and azathioprine. Aliment Pharmacol Ther. 2022 Jan 14.
- Jeong TJ, Kim ES, Kwon Y, Kim S, Seo SW, Choe YH, Kim MJ. Discontinuation of Azathioprine could be considered in pediatric patients with Crohn's disease who have sustained clinical and deep remission. Sci Rep. 2022 Jan 11;12(1):507.
- Kim ES, Kwon Y, Choe YH, Kim MJ. Albumin-to-Globulin Ratio at 1 Year after Anti-Tumor Necrosis Factor α Therapy Can Serve as a Prognostic Biomarker in Pediatric Crohn's Disease Patients. Gut Liver. 2021 Jun 9.
- Kim ES, Kwon Y, Choe YH, Kim MJ. COVID-19-related school closing aggravate obesity and glucose intolerance in pediatric patients with obesity. Sci Rep. 2021 Mar 9;11(1):5494.
- Choi SY, Kim ES, Jeon TY, Lee YM, Lee SM, Choe BH, Choe YH, Kang B. Transmural healing evaluated by magnetic resonance enterography in paediatric patients with Crohn's disease receiving maintenance treatment with biologics. Aliment Pharmacol Ther. 2022 Oct;56(7):1146-1156.
- Choi S, Kim ES, Kwon Y, Kim MJ, Choe YH, Choe BH, Kang B. Vedolizumab Is Safe and Efficacious for the Treatment of Pediatric-Onset Inflammatory Bowel Disease Patients Who Fail a Primary Biologic Agent. J Korean Med Sci. 2022 Sep 26;37(37):e282.
- Kim ES, Kang B. Assessment of Medication Adherence and Pharmacist Intervention Are Important for the Care of Patients with Inflammatory Bowel Disease. Gut Liver. 2022 Sep 15;16(5):665-666.
- Kim ES, Choi S, Choi SY, Park JH, Choe BH, Lee SY, Kim MJ, Choe YH, Kang B. NUDT15 intermediate metabolisers are associated with lower loss of response in paediatric Crohn's disease patients treated by combination treatment with infliximab and azathioprine. Aliment Pharmacol Ther. 2022 Apr;55(8):1008-1015.
- Jeong TJ, Kim ES, Kwon Y, Kim S, Seo SW, Choe YH, Kim MJ. Discontinuation of Azathioprine could be considered in pediatric patients with Crohn's disease who have sustained clinical and deep remission. Sci Rep. 2022 Jan 11;12(1):507.
- Kim ES, Kwon Y, Choe YH, Kim MJ. Albumin-to-Globulin Ratio at 1 Year after Anti-Tumor Necrosis Factor α Therapy Can Serve as a Prognostic Biomarker in Pediatric Crohn's Disease Patients. Gut Liver. 2022 Jan 15;16(1):71-80.
- Kim ES, Kim D, Yoon Y, Kwon Y, Park S, Kim J, Ahn KM, Ahn S, Choe YH, Kim Y-J, Kim MJ. Needs for Increased Awareness of Gastrointestinal Manifestations in Patients With Human Inborn Errors of Immunity, Front Immunol. 2021 Aug; 12;12:698721
- Kim ES, Kwon Y, Choe YH, Kim MJ. COVID-19-related school closing aggravate obesity and glucose intolerance in pediatric patients with obesity. Sci Rep. 2021 Mar 9;11(1):5494.
- Kim ES, Kwon Y, Choe YH, Kim MJ. Upper gastrointestinal tract involvement is more prevalent in Korean patients with pediatric Crohn's disease than in European patients. Sci Rep. 2020 Nov 4;10(1):19032. doi: 10.1038/s41598-020-75938-1. PMID: 33149222; PMCID: PMC7642352.
- Kim ES, Lee KW, Choe YH. The Characteristics and Outcomes of Abernethy Syndrome in Korean Children: A Single Center Study. Pediatr Gastroenterol Hepatol Nutr. 2019 Jan;22(1):80-85
서울특별시 종로구 새문안로 29 (03181) 강북삼성병원
대표전화 1599-8114
팩스번호 02-2001-2117
사업자번호 110-82-02349
Copyright(c) by Kangbuk Samsung hospital. all right reserved.